TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T92517	Calpain-1	B0RYX5	(2S,3S)-2-N-[(2S)-1-[(2S)-2-[[(2S,3R)-1-Amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-3-N-[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]oxirane-2,3-dicarboxamide	Investigative	90644784	C39H60N10O14	893	C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)NC(=O)[C@@H]2[C@H](O2)C(=O)N[C@@H](CO)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@@H](CO)C(=O)N)O	Ki ~ 50000 nM	Poor binder
T92517	Calpain-1	B10NMA	(S)-N-(4-(Isopropylamino)-3,4-dioxo-1-phenylbutan-2-yl)-3-methyl-6-oxo-1,6-dihydropyridine-2-carboxamide	Investigative	42600222	C20H23N3O4	369.4	CC1=C(NC(=O)C=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)C(=O)NC(C)C	IC50 ~ 100000 nM	Poor binder
T92517	Calpain-1	B2UR8D	(S)-N-(4-(Isopropylamino)-3,4-dioxo-1-phenylbutan-2-yl)-3-methyl-4-oxo-1,4-dihydroquinoline-2-carboxamide	Investigative	44446397	C24H25N3O4	419.5	CC1=C(NC2=CC=CC=C2C1=O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)C(=O)NC(C)C	IC50 ~ 50000 nM	Poor binder
T92517	Calpain-1	B34XLA	(2R,3R)-2-N-[(2S,3R)-1-[(2S)-2-[[(2S,3R)-1-Amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]-3-N-[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]oxirane-2,3-dicarboxamide	Investigative	90644791	C38H58N10O15	894.9	C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]2[C@@H](O2)C(=O)N[C@@H](CO)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@@H](CO)C(=O)N)O	Ki ~ 100000 nM	Poor binder
T92517	Calpain-1	B4GUN8	1-Benzyl-N-[(2S)-1-[[(3S)-2-hydroxyoxolan-3-yl]amino]-4-methyl-1-oxopentan-2-yl]-2,3-dihydroindole-5-carboxamide	Investigative	44349727	C26H33N3O4	451.6	CC(C)C[C@@H](C(=O)N[C@H]1CCOC1O)NC(=O)C2=CC3=C(C=C2)N(CC3)CC4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T92517	Calpain-1	B58LOV	(S)-N-(3,4-Dioxo-1-phenyl-4-(pyridin-2-ylmethylamino)butan-2-yl)-3-methyl-6-oxo-1,6-dihydropyridine-2-carboxamide	Investigative	42600464	C23H22N4O4	418.4	CC1=C(NC(=O)C=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)C(=O)NCC3=CC=CC=N3	IC50 = 84750 nM	Poor binder
T92517	Calpain-1	B69BYG	(S)-3-Methyl-N-(4-(methylamino)-3,4-dioxo-1-phenylbutan-2-yl)-6-oxo-1,6-dihydropyridine-2-carboxamide	Investigative	42600221	C18H19N3O4	341.4	CC1=C(NC(=O)C=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)C(=O)NC	IC50 = 91420 nM	Poor binder
T92517	Calpain-1	B7LM8U	(2S,3S)-2-N-[(2S)-1-[[(2S)-5-Amino-1-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1,5-dioxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]-3-N-[(2S)-1-[(2S)-2-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]oxirane-2,3-dicarboxamide	Investigative	90644788	C40H63N11O15	938	C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]2[C@H](O2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N)O	Ki ~ 100000 nM	Poor binder
T92517	Calpain-1	B86WDG	(2R,3R)-3-N-[(2S)-1-[(2S)-2-[[(2S,3R)-1-Amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]-2-N-[(2S)-1-[[(2S)-1-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]oxirane-2,3-dicarboxamide	Investigative	90644796	C38H60N10O15	896.9	C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H]2[C@@H](O2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N)O	Ki ~ 100000 nM	Poor binder
T92517	Calpain-1	BF1W0I	(2S,3S)-3-N-[(2S)-1-[(2S)-2-[[(2S,3R)-1-Amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]-2-N-[(2S)-1-[[(2S)-1-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]oxirane-2,3-dicarboxamide	Investigative	90644787	C38H60N10O15	896.9	C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]2[C@H](O2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N)O	Ki ~ 100000 nM	Poor binder
T92517	Calpain-1	BFD83X	2-[[(2S)-4-Methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]hexyl (2S,3S)-3-[[(2S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate	Investigative	44304781	C35H56N4O8	660.8	CCCCC(COC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC2=CC=CC=C2	IC50 = 100000 nM	Poor binder
T92517	Calpain-1	BKPU36	(2R,3R)-2-N-[(2S)-1-[[(2S)-5-Amino-1-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1,5-dioxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]-3-N-[(2S)-1-[(2S)-2-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]oxirane-2,3-dicarboxamide	Investigative	90644797	C40H63N11O15	938	C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H]2[C@@H](O2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N)O	Ki ~ 100000 nM	Poor binder
T92517	Calpain-1	BN5U2K	[(R)-1-((2R,3S)-3-Benzyl-2-hydroxy-morpholine-4-carbonyl)-2-methyl-propyl]-carbamic acid benzyl ester	Investigative	44315377	C24H30N2O5	426.5	CC(C)[C@H](C(=O)N1CCO[C@H]([C@@H]1CC2=CC=CC=C2)O)NC(=O)OCC3=CC=CC=C3	Ki = 56000 nM	Poor binder
T92517	Calpain-1	BOZ4X3	(S)-N-(4-(Benzylamino)-3,4-dioxo-1-phenylbutan-2-yl)-3-methyl-6-oxo-1,6-dihydropyridine-2-carboxamide	Investigative	42600223	C24H23N3O4	417.5	CC1=C(NC(=O)C=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)C(=O)NCC3=CC=CC=C3	IC50 = 64610 nM	Poor binder
T92517	Calpain-1	BP5O2G	(2R,3R)-2-N-[(2S)-1-[(2S)-2-[[(2S,3R)-1-Amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-3-N-[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]oxirane-2,3-dicarboxamide	Investigative	90644792	C39H60N10O14	893	C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)NC(=O)[C@H]2[C@@H](O2)C(=O)N[C@@H](CO)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@@H](CO)C(=O)N)O	Ki ~ 50000 nM	Poor binder
T92517	Calpain-1	BP8F6S	N-(1-Cyano-3-methylbutyl)-2-((4-fluorophenyl)sulfonamido)-3-methylbutanamide	Investigative	44412929	C17H24FN3O3S	369.5	CC(C)C[C@@H](C#N)NC(=O)[C@H](C(C)C)NS(=O)(=O)C1=CC=C(C=C1)F	IC50 ~ 100000 nM	Poor binder
T92517	Calpain-1	BTM87H	5-Fluoro-3-((S)-3-methyl-2-phenylcarbamoyloxy-butyrylamino)-4-oxo-pentanoic acid	Investigative	11257152	C17H21FN2O6	368.4	CC(C)[C@@H](C(=O)NC(CC(=O)O)C(=O)CF)OC(=O)NC1=CC=CC=C1	IC50 ~ 100000 nM	Poor binder
T92517	Calpain-1	BX21IK	(2R,3R)-3-N-[(2S)-1-[(2S)-2-[[(2S,3R)-1-Amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]-2-N-[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]oxirane-2,3-dicarboxamide	Investigative	90644789	C40H62N10O14	907	C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H]2[C@@H](O2)C(=O)N[C@@H](CO)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@@H](CO)C(=O)N)O	Ki ~ 100000 nM	Poor binder
T92517	Calpain-1	BX9O5Q	(2R,3R)-3-N-[(2S)-1-[(2S)-2-[[(2S,3R)-1-Amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]-2-N-[(2S,3R)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]oxirane-2,3-dicarboxamide	Investigative	90644795	C41H64N10O14	921	C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H]2[C@@H](O2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@@H](CO)C(=O)N)O	Ki ~ 50000 nM	Poor binder
T92517	Calpain-1	BYUR53	(2S,3S)-2-N-[(2S,3R)-1-[(2S)-2-[[(2S,3R)-1-Amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]-3-N-[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]oxirane-2,3-dicarboxamide	Investigative	90644783	C38H58N10O15	894.9	C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2[C@H](O2)C(=O)N[C@@H](CO)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@@H](CO)C(=O)N)O	Ki ~ 100000 nM	Poor binder